ATE71941T1 - Optisches isomeres eines imidazolderivats. - Google Patents

Optisches isomeres eines imidazolderivats.

Info

Publication number
ATE71941T1
ATE71941T1 AT88306250T AT88306250T ATE71941T1 AT E71941 T1 ATE71941 T1 AT E71941T1 AT 88306250 T AT88306250 T AT 88306250T AT 88306250 T AT88306250 T AT 88306250T AT E71941 T1 ATE71941 T1 AT E71941T1
Authority
AT
Austria
Prior art keywords
isomeres
optical
imidazole derivative
imidazole
derivative
Prior art date
Application number
AT88306250T
Other languages
German (de)
English (en)
Inventor
Arto Johannes Karjalainen
Raimo Einari Virtanen
Eino Juhani Savolainen
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10620775&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE71941(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Application granted granted Critical
Publication of ATE71941T1 publication Critical patent/ATE71941T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/58—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Optical Fibers, Optical Fiber Cores, And Optical Fiber Bundles (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Optical Record Carriers And Manufacture Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT88306250T 1987-07-16 1988-07-08 Optisches isomeres eines imidazolderivats. ATE71941T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8716803A GB2206880B (en) 1987-07-16 1987-07-16 Optical isomers of an imidazole derivative
EP88306250A EP0300652B1 (en) 1987-07-16 1988-07-08 Optical isomer of an imidazole derivative

Publications (1)

Publication Number Publication Date
ATE71941T1 true ATE71941T1 (de) 1992-02-15

Family

ID=10620775

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88306250T ATE71941T1 (de) 1987-07-16 1988-07-08 Optisches isomeres eines imidazolderivats.

Country Status (29)

Country Link
US (1) US4910214A (enExample)
EP (1) EP0300652B1 (enExample)
JP (1) JPH0625138B2 (enExample)
KR (1) KR940007311B1 (enExample)
CN (1) CN1022323C (enExample)
AT (1) ATE71941T1 (enExample)
AU (1) AU600839B2 (enExample)
BG (1) BG60473B2 (enExample)
CA (1) CA1337659C (enExample)
CY (2) CY1787A (enExample)
DD (1) DD281807A5 (enExample)
DE (2) DE3867945D1 (enExample)
DK (1) DK165788C (enExample)
ES (1) ES2038757T3 (enExample)
FI (1) FI95375C (enExample)
GB (1) GB2206880B (enExample)
GR (1) GR3003878T3 (enExample)
HK (1) HK56094A (enExample)
HU (1) HU198693B (enExample)
IE (1) IE60456B1 (enExample)
IL (1) IL87076A0 (enExample)
LU (1) LU91010I2 (enExample)
NL (1) NL300117I2 (enExample)
NO (2) NO170579C (enExample)
NZ (1) NZ225362A (enExample)
PT (1) PT88013B (enExample)
SU (1) SU1648248A3 (enExample)
UA (1) UA5560A1 (enExample)
ZA (1) ZA885134B (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2215206B (en) * 1988-02-29 1991-07-03 Farmos Oy 4-substituted imidazole derivatives useful in perioperative care
US5124157A (en) 1989-08-18 1992-06-23 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
US5120713A (en) * 1990-09-10 1992-06-09 Applied Research Systems Ars Holding N.V. Treatment of obesity with an alpha-2-adrenergic agonist and a growth hormone releasing peptide
GB9111732D0 (en) * 1991-05-31 1991-07-24 Orion Yhtymae Oy The use of certain salts of medetomidine and its optically active enantiomers to regulate the rate of transdermal administration of the drugs
GB2281206A (en) * 1993-08-25 1995-03-01 Orion Yhtymae Oy Use of dexmedetomidine
GB9425211D0 (en) * 1994-12-14 1995-02-15 Ucb Sa Substituted 1H-imidazoles
IN187238B (enExample) * 1995-06-30 2002-03-09 Astra Ab
GB9521680D0 (en) * 1995-10-23 1996-01-03 Orion Yhtymo Oy New use of imidazole derivatives
US5866579A (en) * 1997-04-11 1999-02-02 Synaptic Pharmaceutical Corporation Imidazole and imidazoline derivatives and uses thereof
AR015744A1 (es) * 1998-04-01 2001-05-16 Orion Corp Uso de dexmedetomidina para sedacion en terapia intensiva
US6716867B1 (en) 1998-04-01 2004-04-06 Orion Corporation Use of dexmedetomidine for ICU sedation
JP4741131B2 (ja) 1999-10-29 2011-08-03 オリオン コーポレーション 低血圧およびショックの治療または予防
US6388090B2 (en) * 2000-01-14 2002-05-14 Orion Corporation Imidazole derivatives
US7141597B2 (en) * 2003-09-12 2006-11-28 Allergan, Inc. Nonsedating α-2 agonists
BRPI0618643A2 (pt) 2005-11-09 2011-09-06 Combinatorx Inc composição compreendendo um par de fármacos, composição compreendendo um corticosteróide e um imunossupressor dependente de imunofilina não-esteróide, kits e uso
KR101495146B1 (ko) 2006-03-16 2015-02-24 트리스 파마 인코포레이티드 약물 - 이온교환 수지 복합체를 함유하는 변형 방출 제제
US7795263B2 (en) * 2008-07-08 2010-09-14 Wildlife Laboratories, Inc. Pharmaceutical combination for and method of anesthetizing and immobilizing non-domesticated mammals
WO2010065547A1 (en) * 2008-12-01 2010-06-10 Map Pharmaceuticals, Inc. Inhalation delivery methods and devices
WO2010074753A1 (en) 2008-12-23 2010-07-01 Map Pharmaceuticals, Inc. Inhalation devices and related methods for administration of sedative hypnotic compounds
CA2762107A1 (en) * 2009-05-15 2010-11-18 Recro Pharma, Inc. Sublingual dexmedetomidine compositions and methods of use thereof
CN101671305A (zh) * 2009-09-29 2010-03-17 北京华禧联合科技发展有限公司 一种拆分美托咪定的左旋及右旋对映体的方法
CN102464619A (zh) * 2010-11-17 2012-05-23 桑迪亚医药技术（上海）有限责任公司 一种左旋4-[1-(2,3-二甲基苯基)乙基]-1r-咪唑消旋化方法
US20130096170A1 (en) 2011-10-14 2013-04-18 Hospira, Inc. Methods of treating pediatric patients using dexmedetomidine
WO2013069025A1 (en) 2011-11-11 2013-05-16 Neon Laboratories Ltd. "process for the preparation of dexmedetomidine"
SG10201604653TA (en) 2011-12-11 2016-07-28 Recro Pharma Inc Intranasal dexmedetomidine compositions and methods of use thereof
US8242158B1 (en) 2012-01-04 2012-08-14 Hospira, Inc. Dexmedetomidine premix formulation
ITMI20120311A1 (it) * 2012-02-29 2013-08-30 Edmond Pharma Srl Procedimento per la risoluzione di medetomidina e recupero dell'enantiomero indesiderato
WO2014028610A1 (en) 2012-08-15 2014-02-20 Tris Pharma, Inc. Methylphenidate extended release chewable tablet
WO2014060638A1 (en) 2012-10-15 2014-04-24 Orion Corporation A veterinary method of alleviating noise aversion
CN105764496B (zh) 2013-10-07 2020-09-25 帝国制药美国公司 用于经皮递送非镇静量的右旋美托咪啶的方法和组合物
RU2646512C2 (ru) 2013-10-07 2018-03-05 ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. Устройства для трансдермальной доставки дексмедетомидина и способы их применения
TWI709417B (zh) 2013-10-07 2020-11-11 美商帝國製藥美國股份有限公司 使用右美托咪啶經皮組成物用於治療注意力不足過動症、焦慮及失眠的方法及組成物
CN105175339B (zh) * 2015-10-09 2018-01-16 辰欣药业股份有限公司 一种制备盐酸右美托咪定的方法
US9717796B1 (en) 2016-04-20 2017-08-01 Slypharma, Llc Heat sterilizeable, premixed, ready to use dexmedetomidine solution packaged in a flexible plastic container
FR3054218B1 (fr) * 2016-07-22 2020-03-06 Universite De Rouen Procede de dedoublement de sels de baclofene
US11160791B2 (en) 2018-11-01 2021-11-02 Medefil, Inc. Dexmedetomidine injection premix formulation in ready to use (RTU) bags
CN115197148B (zh) * 2021-04-02 2023-12-12 四川大学华西医院 一种5-苄基咪唑类化合物及其制备方法和用途
CN114671811A (zh) * 2022-04-14 2022-06-28 南京正科医药股份有限公司 一种右美托咪定拆分副产物的外消旋化回收方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU518569B2 (en) * 1979-08-07 1981-10-08 Farmos-Yhtyma Oy 4-benzyl- and 4-benzoyl imidazole derivatives
GB2092569B (en) * 1981-02-05 1984-09-19 Farmos Oy Substituted imidazole derivatives and their preparation and use
GB2101114B (en) 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use
FI844786A0 (fi) 1984-12-04 1984-12-04 Farmos Oy Terapeutiskt utnyttjbar foerening.
DE3531682A1 (de) * 1985-09-05 1987-03-12 Thomae Gmbh Dr K (+)-6-chlor-5,10-dihydro-5-((1-methyl-4- piperidinyl)acetyl)-11h-dibenzo(b,e)(1,4) diazepin-11-on, seine isolierung und verwendung als arzneimittel

Also Published As

Publication number Publication date
NO2003004I2 (no) 2005-03-21
SU1648248A3 (ru) 1991-05-07
HUT48218A (en) 1989-05-29
CN1022323C (zh) 1993-10-06
IE60456B1 (en) 1994-07-13
HU198693B (en) 1989-11-28
DE3867945D1 (de) 1992-03-05
PT88013B (pt) 1995-03-01
CN1030576A (zh) 1989-01-25
GR3003878T3 (enExample) 1993-03-16
CY2004006I1 (el) 2009-11-04
JPH0625138B2 (ja) 1994-04-06
NL300117I1 (nl) 2003-05-01
DK386288D0 (da) 1988-07-11
CA1337659C (en) 1995-11-28
JPS6434968A (en) 1989-02-06
DE10399005I1 (de) 2003-06-05
NO170579B (no) 1992-07-27
CY1787A (en) 1995-10-20
IL87076A0 (en) 1988-12-30
ES2038757T3 (es) 1993-08-01
FI882819A0 (fi) 1988-06-14
FI95375B (fi) 1995-10-13
DK165788B (da) 1993-01-18
DD281807A5 (de) 1990-08-22
NO883155L (no) 1989-01-17
AU1894188A (en) 1989-01-19
UA5560A1 (uk) 1994-12-28
DE10399005I2 (de) 2012-06-06
EP0300652B1 (en) 1992-01-22
ZA885134B (en) 1989-04-26
LU91010I2 (fr) 2003-06-19
NO170579C (no) 1992-11-04
NO883155D0 (no) 1988-07-15
NZ225362A (en) 1990-07-26
US4910214A (en) 1990-03-20
EP0300652A1 (en) 1989-01-25
KR940007311B1 (ko) 1994-08-12
BG60473B2 (bg) 1995-04-28
IE882174L (en) 1989-01-16
FI95375C (fi) 1996-01-25
DK165788C (da) 1993-06-14
GB2206880A (en) 1989-01-18
PT88013A (pt) 1989-06-30
DK386288A (da) 1989-01-17
FI882819L (fi) 1989-01-17
CY2004006I2 (el) 2009-11-04
GB2206880B (en) 1991-04-24
HK56094A (en) 1994-06-03
KR890002030A (ko) 1989-04-07
AU600839B2 (en) 1990-08-23
GB8716803D0 (en) 1987-08-19
NL300117I2 (nl) 2003-10-01

Similar Documents

Publication Publication Date Title
ATE71941T1 (de) Optisches isomeres eines imidazolderivats.
LV10452A (lv) (1H-Azol-1-ilmetil)-aizvietotu benzotriazolu atvasinajumu iegusanas metode
DE3883976D1 (de) Segmentierte gleitlagerungseinrichtung für tragbare drehmaschine.
PL144899B1 (en) Method of obtaining novel triazine derivatives
BG36932A3 (bg) Метод за получаване на 1-(3-хидрокси-4-метаксибензоил)-3- хидрокси-2-пиролидинон
BG40148A3 (bg) Метод за получаване на хетероциклично съединение
DE3873562D1 (de) Beta-alkylmelatonine.
FI821316A7 (fi) Menetelmä uusien substituoitujen imidatsoli- ja imidatsoliinijohdannaisten valmistamiseksi.
FI905127A7 (fi) Menetelmä substituoidun tai substituoimattoman 4(5)-(omega-aminoalkyyl i)imidatsolin valmistamiseksi
BG38637A3 (en) Method for preparing 2- exo- hydroxy- 7- oxabicyclo [2, 2, 1] heptanes
DE68911610D1 (de) Antigeschwür-Alkyldithio-Chinolin-Derivate.
BG38337A3 (en) Method for preparing 6 alpha- methylhydrocortisonic derivatives
FI872489A7 (fi) Menetelmä uusien aralkyyli -imidatsolijohdannaisten valmistamiseksi.
IT1190526B (it) Apparecchio perfezionato per la sfogliatura di piccoli tronchi d'albero per la produzione di impiallacciatura
FI861643A0 (fi) Nya substituerade 2-(n-alkinyl-n-fenylamino)imidazolinderivat, deras syraadditionssalter, dessa innehaollande laekemedel och foerfarande foer deras framstaellning.
AU572515B2 (en) Lowering the cloud point of hydrodewaxed base stocks
BG40812A3 (en) Method for preparing derivatives of pyroxycam
IT8023833A0 (it) Griffa per la sospensione di linee aeree per filovie.
ATE66459T1 (de) Herstellungsverfahren von trifluormethylverbindungen.
KR900009634A (ko) 이미다졸 유도체의 제조방법
BG40804A3 (en) Method for preparing aniline derivatives